Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials.

Garcia-Doval, Ignacio

Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. [electronic resource] - Archives of dermatology Apr 2012 - 463-70 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1538-3652

10.1001/archdermatol.2011.2768 doi


Adult
Age Factors
Aged
Anti-Inflammatory Agents--adverse effects
Antibodies, Monoclonal--adverse effects
Biological Products--adverse effects
Female
Humans
Immunosuppressive Agents--adverse effects
Keratolytic Agents--adverse effects
Male
Middle Aged
PUVA Therapy--adverse effects
Patient Selection
Proportional Hazards Models
Psoriasis--classification
Randomized Controlled Trials as Topic
Risk Assessment
Spain